Enhanced macrophage tribbles-1 expression in murine experimental atherosclerosis

Area of Science:

• Cardiovascular Biology
• Immunology
• Molecular Cell Biology

Background:

• Atherosclerotic plaque development involves complex cell interactions and signaling mediators.
• Tribbles proteins are emerging as key regulators of pro-inflammatory signaling pathways.

Purpose of the Study:

• To investigate the expression patterns of all three tribbles proteins in mouse atherosclerotic plaques.
• To elucidate the role of Interleukin-1 (IL-1) in controlling tribbles expression during atherosclerosis.
• To determine the functional impact of Tribbles homolog 1 (TRB-1) on inflammatory responses in macrophages.

Main Methods:

• Immunohistochemical analysis of atherosclerotic plaques in ApoE-/- and ApoE-/-IL1R1-/- mouse models.
• In vitro studies involving macrophage manipulation with TRB-1 and its mutants.
• Quantification of pro-inflammatory cytokine production (IL-6, IL-12) using cell-based assays.

Main Results:

• All three tribbles proteins were expressed in vascular smooth muscle cells, endothelial cells, and macrophages within atherosclerotic plaques.
• ApoE-/-IL1R1-/- mice exhibited a reduced percentage of TRB-1 expressing macrophages compared to ApoE-/- mice.
• Overexpression of TRB-1 in macrophages significantly attenuated IL-6 and IL-12 production in response to pro-inflammatory stimuli.
• The kinase domain of TRB-1 was sufficient to mediate this inhibitory effect.

Conclusions:

• Tribbles proteins are expressed in key cell types within atherosclerotic lesions.
• IL-1 signaling influences TRB-1 expression in macrophages during atherosclerosis.
• TRB-1 acts as a negative regulator of pro-inflammatory cytokine production, highlighting its potential as a therapeutic target in atherosclerosis.